Molecular Profiling & Precision Medicine Innovation
Educational Webinar Series from Caris Life Sciences
Join us to explore and discuss the latest innovations and offerings in molecular science with Caris medical and scientific staff.
Live webinars every Tuesday at 3 pm CT & every Friday at 10 am CT.
Space is limited. Make plans to attend today.
Helpful Webinar Tips:
- Ensure you have a strong internet connection (WiFi can be spotty).
- Use Chrome if possible, Internet Explorer is not optimized.
- Double check that the volume on your device is turned on (not muted).
ON-DEMAND WEBINAR REPLAYS
Biomarker-Guided Therapeutics in CRC
Artificial Intelligence-Driven Cancer Type Similarity
Assessment for CUP – MI GPSai™ Overview & Case Review
Matthew Oberley, M.D. Executive Director, Caris Pathology
|The Role of Molecular Profiling for CUP Cases
David Arguello, M.D.
Manager, Biomarker & Drug Intelligence
Exploring Guideline-Directed Profiling by RNA
PD-L1 Testing by Tumor Type – Testing with the Appropriate
Guideline-Directed Profiling for Breast, and Head and Neck Cancers
Guideline-Directed Profiling for Pancreatic Cancer
|RNA is the Superior Method of Gene Fusion Analysis
David Spetzler, M.S., Ph.D., MBA
President and Chief Science Officer
The Complicated World of PD-L1 Testing – What
NCCN Guidelines® & Caris Testing
Respect the Tissue – Microdissection and Limited Tissue Testing
Webinars are provided for informational and educational purposes only. These events are not CME accredited. Decisions on patient care and treatment must be based on the independent medical judgment of the treating physician, taking into consideration all available information concerning the patient’s condition.